Informed Consent for Vivabioma™ Gut Microbiome Analysis Services

Version VB-CI-2026-01 · Effective from September 14, 2026 · Replaces the version dated 2 March 2026 ·

Applicable to Vivabioma Starter, Advanced and Ultra, including reinterpretations or upgrades purchased on the basis of retained data.

This Consent explains the analysis of your sample and the processing of the resulting data. It forms part of the contract together with the Legal Terms, Privacy Policy, Cookie Policy, Information Update and Sample Repeat Policy, Returns, Shipping and Replacement Policy, and the product conditions shown before purchase. In the event of any conflict regarding microbiome analysis, the sample or the consents described here, this document shall prevail; mandatory law shall always prevail.

1. Summary: the essentials

This summary does not replace the full text. Please read it in full before accepting.

•      We analyse the genetic material of microorganisms present in a stool sample using shotgun metagenomics and issue the reports included in the product purchased.

•      The purpose is not to study your human DNA. The sample contains human cells and human fragments may be captured incidentally during sequencing; they are filtered out and are not used to infer your genetic characteristics.

•      The consumer service is intended for information and wellness purposes. It does not diagnose or rule out disease, does not by itself measure inflammation, permeability or SIBO, and cannot be used to choose antibiotics or treatments.

•      The microbiome changes over time. The report is an estimate of the state at the time the sample was collected and depends on collection, transport, technology, reference databases and the models used.

•      Sections labelled health, immunity, risk, prediction, resistome or recommendation express associations, indices or functional potential; they are not individual clinical probabilities or prescriptions.

•      The sample is normally destroyed between 60 and 120 days after results are issued and always before six months, unless there is a quality incident or a notified legal obligation.

•      The main consent is essential to provide the service. Research, marketing communications and Professional Access are separate options.

•      You may withdraw each optional permission and exercise your rights. Withdrawal does not make previous processing unlawful and does not allow information that has already been irreversibly anonymised to be withdrawn.

2. Who provides the service and how to contact us

Service provider and data controller: GENELINK, S.L., owner of Vivabioma™. Tax ID B98649494. Registered address: calle Arquitecto Mora 5, floor 2, door 4, 46010 Valencia, Spain. Healthcare authorisation no. 11540 issued by the Conselleria de Sanidad de la Generalitat Valenciana.

•      General contact and incidents: info@vivabioma.com · Telephone: +34 960 090 596

•      Data protection and exercise of rights: lopd@tellmegen.com

•      Data Protection Officer: dpo@tellmegen.com

•      Supervisory authority: Spanish Data Protection Agency or the authority in your country of residence.

Vivabioma and tellmeGen belong to GENELINK and share certain corporate systems and privacy channels. This does not authorise combining data from both services for research, profiling or new products: such combination requires the specific voluntary option in section 20.

The service is organised from Spain. Laboratories and providers, their location, functions and safeguards are identified in the list available through the Privacy Policy. A change of provider does not expand the purposes or reduce your rights.

3. Intended purpose and nature of the service

3.1 Vivabioma analyses a stool sample to estimate taxonomic composition, diversity and potential microbial functions, and to generate the modules included in Starter, Advanced or Ultra. The intended purpose of the direct-to-consumer version is informational, educational and wellness-related.

3.2 Commercial or interface terms such as “health”, “immunity”, “risk”, “prediction”, “resistance”, “biological age”, “precision”, “personalised” or “plan” describe categories, indices or algorithmic comparisons within this purpose. They do not mean diagnosis, clinically validated prognosis, antimicrobial susceptibility, prescription or a guaranteed outcome.

3.3 Regulatory classification depends on the intended purpose and on all claims made in labelling, instructions, the Website, advertising and sales, not only on this document. If a module is offered as a medical device or healthcare service in a country, the pre-contractual information sheet will expressly identify its status, professional, laboratory and applicable pathway; nothing in this Consent replaces those obligations.

3.4 The purchase does not in itself create a doctor-patient relationship. A professional consultation purchased separately may have the nature stated in its terms and under the law of the relevant country, without retroactively turning all reports into diagnoses.

4. What each product includes

•      Starter: diversity and balance; potential microbial functionality and metabolism.

•      Advanced: the above plus health and immunity modules based on microbial patterns or associations. They do not directly measure hormones, inflammation, permeability, SIBO, intolerances or disease.

•      Ultra: everything included in Advanced, personalised recommendations, resistome and, where offered, scores or comparisons using artificial intelligence models. It does not predict future disease with certainty, identify an ideal diet or determine which antibiotic you need.

All products use shotgun metagenomics. The advertised number of reports, microorganisms, functions or reads describes the configuration or a technical target of the relevant version; it does not guarantee the same number of usable reads after quality control and human-read filtering, identification of all microorganisms, or uniform coverage.

The order confirmation and the version shown in each report determine the content purchased. Modules may be updated due to new evidence, correction, safety or regulatory changes, while respecting the contract and without presenting a future service sold separately as included.

5. Process, quality control and upgrades

5.1 You collect the sample according to the instructions, register it and return it using the authorised materials and transport. The laboratory extracts and sequences the genetic material; the software filters, classifies and estimates profiles and functions; it then generates the reports available in your account.

5.2 The sample is not homogeneous and the result depends on the portion collected, date, recent diet, bowel transit, medicines, contamination, temperature, time and transport. Failure attributable to you to follow the instructions may alter or invalidate the analysis.

5.3 If the sample does not pass quality control, the first repeat is free in all cases and includes a new kit. If a second sample also fails, you may choose between a third free repeat or termination of the contract with reimbursement in accordance with the repeat policy. Thereafter, additional analyses are charged at the current price, which will be communicated before you confirm them. Where invalidity results from an attributable failure to follow collection, storage, labelling or shipping instructions, the replacement-material rules in the Legal Terms will apply.

5.4 A Starter → Advanced or Advanced → Ultra upgrade may consist of reinterpreting data already obtained, without a new sample or new sequencing. It requires a separate purchase and, if it unlocks new health or interpretation categories, confirmation of the current version of this Consent. Upgrade availability depends on quality, retained format, country and technical compatibility.

5.5 Longitudinal comparisons require a new sample and do not eliminate technical or temporal variability. A change between reports does not by itself demonstrate that an intervention caused improvement or deterioration.

6. Reasonably expected benefits

•      Obtain an estimate of microbial composition and diversity at the time of sampling.

•      Explore potential metabolic functions inferred from genes or microbial profiles.

•      Have educational material to discuss with a doctor, dietitian-nutritionist or other professional.

•      Observe general associations between microbiome, habits and wellness without establishing individual causality.

There is no guarantee that the report will provide a health benefit, resolve symptoms, confirm a suspicion, recommend a useful intervention or change as a result of a specific behaviour.

7. Scientific and technical limitations

7.1 Temporal and sample variability

The microbiome varies with diet, sleep, stress, exercise, travel, infections, bowel transit, age and, especially, antibiotics and other medicines. Two samples from the same person may differ without there being an error.

7.2 Classification, coverage and reference databases

Databases are incomplete and biased toward more extensively studied populations and environments. There may be undescribed microorganisms, unclassified sequences or assignments limited to a particular taxonomic level. The ability to detect bacteria, archaea, fungi, viruses or parasites depends on the product, preparation, abundance, sequencing depth and reference database; the analysis is not an exhaustive screening for all of them.

7.3 Relative abundance, viability and function

Proportions are relative estimates and may change because another microorganism changes; they are not absolute counts. Detecting DNA does not demonstrate that the microorganism is alive, active or located in a specific region. An inferred function indicates genetic potential, not expression, a measured metabolite or a demonstrated physiological effect.

7.4 Contamination and detection limits

Kit materials, the environment, collection and the laboratory can introduce low-abundance signals. Controls reduce but do not eliminate false positives, false negatives, classification errors, batch effects or loss of low-abundance microorganisms.

7.5 Health associations

Most of the evidence is observational. An association does not demonstrate that a microorganism causes a condition or that modifying it prevents that condition. A “normal” result does not rule out disease, and an altered index does not confirm it.

7.6 Potentially pathogenic microorganisms

Detection of a microorganism associated with infection in certain contexts does not demonstrate infection, clinically relevant colonisation or a need for treatment. Vivabioma does not perform cultures, antimicrobial susceptibility testing, clinical confirmation or active follow-up. Assessment is the responsibility of a professional and may require a specific test.

7.7 Resistome (Ultra)

The resistome identifies genes or fragments associated with resistance in the microbial community. It does not always allow the gene to be attributed to a species, determine whether it is expressed, whether it confers phenotypic resistance or whether the microorganism will cause infection. It cannot be used to choose, start, rule out or change an antibiotic; this requires diagnosis, an appropriate clinical sample and antimicrobial susceptibility testing where appropriate.

7.8 AI models, scores and predictions (Ultra)

The models compare your profile with reference datasets and generate relative indices according to the variables and versions described. They do not necessarily calculate an absolute clinical probability and have not been validated for all ages, populations, countries or diseases. Bias, uncertainty and version changes may exist. The output does not determine legal or healthcare decisions, and you may request review by a member of our team.

7.9 Recommendations, probiotics and supplements (Ultra)

Recommendations are general dietary and lifestyle guidance, not an individualised diet or prescription. They do not guarantee effectiveness. Consult a professional beforehand if you have symptoms, digestive disease, special nutritional needs, are pregnant or breastfeeding, take medication, follow a prescribed diet or have experienced difficulties with eating.

7.10 Third-party services and security

External interpretations may differ and are subject to their own terms. Once you download or share information, you control its custody. We apply appropriate measures, but no system can promise absolute security.

8. Before any healthcare or nutritional decision

A qualified professional should assess any result in the context of symptoms, medical history, medication and validated tests. If a decision depends on a finding, it should be confirmed using the appropriate clinical test at an authorised centre or laboratory.

This Consent is not a waiver of your rights. GENELINK is not liable for decisions made contrary to these warnings where the damage does not result from its own breach, without excluding liabilities that cannot legally be waived.

9. Prior information, materials and consultations

9.1 Before acceptance, this document, the product information sheet, limitations, frequently asked questions and financial conditions are made available to you. You may raise reasonable questions through support channels before sending the sample.

9.2 The platform may include tutorials, glossaries and explanations. The materials are educational and evolve with the evidence; they do not constitute individual clinical follow-up.

9.3 Where a consultation is offered, the provider, qualifications, purpose, price, country and informational or healthcare nature will be identified before booking. It is not an emergency service and does not guarantee that all questions will be resolved.

9.4 Where available, the consultation is voluntary and is purchased separately at the price indicated on the platform. Before accepting this Consent, you are expressly informed of its availability and cost, and by accepting you declare that it has been offered to you and that you freely choose to use it or continue without it; this declaration is recorded together with your consent. It is not research consent, a waiver of rights or a release of GENELINK from liability, and you may request it at any time.

10. Right not to know and display control

You may decide not to open a category or, before publication, request that it be hidden where the platform allows. Once opened, downloaded or communicated, we cannot make you cease to know it or withdraw copies held by third parties.

This preference does not prevent communications that are essential due to a legal obligation, security, correction of a material error or serious risk; they will be limited to what is necessary.

11. Unexpected findings and corrections

Unexpected information may appear, including potentially pathogenic microorganisms or resistance genes. It is presented with warnings and a recommendation for professional assessment. Vivabioma does not continuously monitor your data and does not act as an alert service.

Findings are not reported to authorities or third parties unless legally required. If quality control reveals a material error in a report, we may correct it, temporarily withdraw it and provide you with the corrected version.

The profile does not by itself reveal family inheritance, but it may reflect shared habits, diet or living environment. Consider carefully with whom you share it.

12. Prohibited uses

You must not use or provide the reports for:

•      self-diagnosis, self-medication, selection of antibiotics or replacement of professional care;

•      employment, recruitment, promotion, insurance, immigration or discriminatory decisions;

•      forensic purposes, proof of parentage or identification of another person;

•      presenting them as a validated clinical test when they are not; or

•      any unlawful purpose or purpose that infringes third-party rights.

You may not send another person’s sample or data without valid consent or documented representation. Use of reports and proprietary content is also governed by the Legal Terms.

13. Adults, multiple purchases and gifts

Purchase requires being at least 18 years old and having contractual capacity. For orders involving several people or gifts, the payer does not consent on behalf of other adults and does not gain access to their results. Each participant must identify themselves and accept individually before analysis, including each voluntary option.

14. Minors and persons requiring support in exercising legal capacity

14.1 Contracting requires being 18 years of age or older. A minor may not purchase the service or register a kit themselves. The service is not available to children under three years of age.

14.2 The service may be purchased for a minor or for a person whose legal capacity has been judicially modified through their legal representative, who must provide evidence of that status. The representative undertakes to explain the content of this document to that person in a manner appropriate to their age and level of understanding and to take their views into account.

14.3 Mandatory proof. Before the sample is processed, you must provide through the platform:

•      Valid identity document or passport of the person giving authorisation.

•      Identity document, passport or birth certificate of the minor.

•      Family record book, full birth certificate or court order establishing guardianship or custody and proving the relationship or representation.

If parental responsibility is shared, signed authorisation from both parents is required unless there is a court order assigning that decision to only one parent, in which case it must be provided. Documents drafted in a language other than Spanish or English must be accompanied by a translation.

14.4 This verification reflects our duty to make reasonable efforts to confirm that the person giving consent actually holds parental responsibility, guardianship or support authority. We do not begin the analysis until this has been verified. If the documentation is not provided or is insufficient within 30 calendar days of receipt of the order, we will cancel the service and apply the Returns Policy.

14.5 Supporting documentation is retained solely as evidence of authority and to prevent unauthorised analyses, with access restricted to authorised personnel, while the account remains active and during applicable limitation periods for liability. It is not used for any other purpose.

14.6 Scope of a minor’s report. Reports for minors do not include the resistome or personalised recommendations, and health and immunity content, where available, is presented with enhanced warnings and is not intended for paediatric diagnosis. This is because evidence on the microbiome in paediatric populations is more limited and the childhood microbiome changes very rapidly.

14.7 Data relating to minors are included in research only where there is specific authorisation from the person holding legal representation and with any additional safeguards required by the project, category and country, including ethical review where appropriate.

14.8 On reaching the age of 18, the data subject may request ownership of their account. From that point onward, they make decisions for themselves, accept this Consent in their own name and may exercise all their rights, including erasure. Access by their former representative ends when ownership changes.

14.9 Persons with support measures. The same evidence requirements in section 14.3 apply, replacing parentage documentation with the court order or deed establishing the support and its scope. The person providing support must inform the individual and respect their will, wishes and preferences; representation is not presumed solely because of a disability.

15. The biological sample

15.1 The sample is used for the service and quality controls. This Consent does not authorise its storage in a biobank, creation of a research collection, transfer for research, or use for reproductive, forensic or human identification purposes.

15.2 It is normally destroyed between 60 and 120 days after results are issued and, in all cases, before six months. An open incident, repeat test, safety investigation or legal obligation may require longer retention; this will be limited to the time necessary and communicated where appropriate.

15.3 Any future use of the physical sample itself for biomedical research will require separate consent and the applicable project, collection or biobank framework and ethical review. The research consents in section 20 relate to data, not the physical sample.

16. Incidental human DNA and resulting data

16.1 A stool sample contains human and microbial material. Although the analysis targets the microbiome, human fragments may be captured incidentally during sequencing. Processing of those fragments is limited to filtering, quality control, security and deletion in accordance with the technical lifecycle; they are not interpreted to determine traits, relatedness, predisposition or genetic identity.

16.2 Ordinary reports and exports contain microbial profiles or processed data available for the product, not an interpretation of the human genome or, unless expressly stated with specific safeguards, raw files without host filtering.

16.3 The microbial profile is not in itself human “genetic data” within the meaning of the GDPR. However, microbiome information, questionnaires, incidental human fragments and inferences may reveal health information or indirectly identify a person; as a precaution, they are protected as special-category data while they remain personal data.

17. Retention, downloads and erasure

17.1 Reports, profiles, processed data and the necessary technical files remain accessible or retained while the account is active and as long as necessary for consultation, support, quality control, comparison and purchasable upgrades. We periodically review that need and you may request erasure.

17.2 You may download the formats available for your product. Deletion of primary files may prevent future upgrades, reanalysis, comparisons or checks; you will be warned before an irreversible deletion is carried out.

17.3 Erasure or account closure does not extend to data that must be retained in blocked form due to legal obligations, quality, security, taxation or defence of legal claims. Such data are not used for other purposes and are deleted when the retention period expires.

17.4 Backups are deleted or overwritten according to their cycles, with a maximum target of 90 days from operational deletion, except for blocked copies required by law or security needs.

18. Professional Access

You may authorise an identified professional to view specific categories for the period shown. Activation requires a separate action and can be revoked; revocation prevents new access but does not delete copies already downloaded or lawfully incorporated into the professional’s records.

GENELINK is responsible for the platform within the scope of its obligations. The professional is responsible for their authorisation to practise, confidentiality, legal basis and subsequent use, unless the information sheet identifies them as a professional directly engaged by GENELINK.

19. Processing necessary to provide the service

To register the sample, sequence, filter, generate and host reports, we need to process the data described. The contractual legal basis is Article 6(1)(b) GDPR and, for health-related data, incidental human fragments or other special categories, your explicit consent under Article 9(2)(a) GDPR. Without the main consent, we cannot start or continue the analysis.

Required data: identity and contact details; order, payment and logistics; kit code; sample; sequencing and quality-control technical data; profile and reports; mandatory responses for the module purchased; account security and use; and, where applicable, representation. Optional questions will be identified as such; omitting them may limit content that depends on them.

You must provide accurate information and not deliberately omit data that would make a recommendation unsafe. We do not clinically verify all self-reported responses.

20. Research, development and artificial intelligence: voluntary options

20.1 No option in this section is required to purchase, receive reports, access the standard price or request support. Each is decided separately and can be withdrawn just as easily. Data will be used only within the categories selected.

20.2 The covered activities are limited to the study of the microbiome, nutrition, habits, wellness and health; improvement of methods, controls, classifications, reports and models; and evaluation of their performance, biases and safety. A materially different or higher-risk purpose requires information and, where appropriate, new consent.

•      (a) Internal research and improvement: validation and improvement of GENELINK algorithms, reports, knowledge bases, user experience and AI models.

•      (b) External scientific research: projects with universities, healthcare centres, scientific societies or non-profit organisations.

•      (c) Commercial research and development: projects with nutrition, wellness, health, biotechnology, industrial or other commercial partners, including validation or development of products and services.

20.3 Projects use the minimum necessary data, normally pseudonymised or anonymised, and exclude direct identifiers unless there is a justified need. Confidentiality, access controls, prohibition of re-identification, processor/joint-controller/controller agreements and ethical review are imposed where appropriate.

20.4 Available information on research lines, types of partners, countries, data categories and governance criteria is maintained on the Website or in your privacy area. The physical sample is not transferred under these options.

20.5 Research may produce publications, algorithms, models, patents, knowledge bases, products or revenue for GENELINK or partners. Results that could reasonably identify you are not published and, unless specifically agreed, your participation does not create intellectual property rights or an economic entitlement.

20.6 When you withdraw an option, new inclusions and future processing dependent on it cease. This does not affect prior lawful uses, legal obligations, publications already made or data that have been irreversibly anonymised. For already trained models, we will assess any required withdrawal, deletion or technical mitigation; a model may continue if it no longer contains personal data reasonably linkable to you or if another valid legal basis applies. We do not promise technical impossibility of extraction without verifying it.

20.7 We will communicate withdrawal to recipients where appropriate unless this is impossible or involves disproportionate effort, and we will keep a record. You may view or download the status of each option.

21. Data protection information

21.1 Controller. GENELINK, S.L., with the details in section 2.

21.2 Additional legal bases. Legal obligation for expressly established tax, healthcare or quality duties; legitimate interests for security, fraud prevention and defence of claims, following a balancing test; specific consent for Professional Access and research. We do not rely on a legal obligation where there is no applicable rule establishing it.

21.3 Recipients. Laboratories, hosting, infrastructure, logistics, payments, support and authorised professionals. You may request the specific list of processors and sub-processors, including their location and function, by writing to lopd@tellmegen.com. Research partners are disclosed by category or project as appropriate.

21.4 Transfers. Main processing takes place in the EEA according to the current list. If a function involves an international transfer, an adequacy decision, standard contractual clauses or another valid safeguard will be used, together with supplementary measures where necessary.

21.5 Automation. Reports are generated automatically, but do not by themselves produce legal effects or equivalent decisions. You may request an explanation and human review, provide your point of view and challenge an output by writing to lopd@tellmegen.com.

21.6 Rights. You may access, rectify, erase, restrict or object where applicable, request portability and withdraw consent. We normally respond within one month, extendable by up to two further months due to complexity or the number of requests, informing you within the first month. You may lodge a complaint with the supervisory authority.

21.7 Security. We apply pseudonymisation, encryption, access controls and other appropriate measures, subject to review. If a breach is likely to result in a high risk, we will notify you without undue delay as required by law. We do not use expressions implying absolute security.

22. Changes of control, restructuring and closure

22.1 In a merger, demerger, financing, asset sale, transfer of Vivabioma, insolvency or business-continuity process, during the due-diligence phase only strictly necessary aggregated, statistical or pseudonymised data may be shared, under confidentiality agreements, minimisation and access controls. Individually identifiable files or microbial profiles attributable to a specific person will never be provided.

22.2 If the controller changes, the successor assumes this Consent and your preferences without expanding the purposes. We will inform you without undue delay and, where possible, before the successor begins processing your data, providing its identity and contact details. You may then withdraw options, export your data or request erasure. New material purposes require a new legal basis or consent.

22.3 If there is no lawful continuity, the data will be erased or anonymised except for mandatory blocked records. These rules do not in themselves authorise a standalone sale of personal data or samples.

23. Liability and user conduct

23.1 GENELINK is responsible for due care in the contracted analysis, security and data protection in accordance with the law. It does not guarantee a particular microorganism, result, benefit or recommendation where the limitations described reasonably prevent such a guarantee.

23.2 To the extent that damage does not result from its own breach, GENELINK is not liable for decisions made contrary to sections 3, 7 and 8; third-party interpretations; inaccurate self-reported information; voluntary disclosure; or invalidity caused by an attributable failure to comply with collection, storage or shipping requirements.

23.3 Nothing limits liability for fraud or gross negligence, death or injury caused by negligence, defective products, lack of conformity, attributable breaches of privacy or confidentiality, essential obligations or non-waivable consumer rights.

24. Right of withdrawal and start of the service

The withdrawal period is 14 calendar days. Withdrawal and returns are governed by the Legal Terms and the Returns, Shipping and Replacement Policy, available before contracting. This Consent does not in itself constitute a request for early commencement or acknowledgement of loss of the right of withdrawal: where applicable, these will be obtained separately during checkout or activation. Once unsealed, the sealed kit may fall within the statutory hygiene exception, without affecting the conformity guarantee.

25. Incidents, complaints and security

Report errors, damaged kits, unauthorised access or security problems to info@vivabioma.com. We record and assess communications and may correct, temporarily withdraw or reissue reports. You may also contact the competent healthcare, consumer or data-protection authorities.

26. Availability by country

Availability depends on the country of residence, purchase, collection, shipping, laboratory and delivery of results. Sample transport is subject to rules and customs requirements. Vivabioma may prevent contracting, require documentation, adapt pathways, exclude modules or withdraw the service where local requirements cannot be met, with the applicable contractual and consumer remedies.

You must not circumvent controls through false locations, forwarding arrangements or unauthorised transfer of samples. Known local particulars are provided on the Website and in Annex I; they do not replace an up-to-date local assessment.

27. Amendments and version record

Each version has a code and date. Clarifying, legal, technical or security changes will be communicated where appropriate. If purposes, data categories, recipients or a consented option are expanded, a new affirmative action will be requested before the change is applied to existing data where legally required.

You may view and download the accepted version from your account or request it from support, and you may request the version history at info@vivabioma.com. A new version does not retroactively replace evidence of the previous one.

28. Language, applicable law and jurisdiction

The original is in Spanish. Translations are provided to aid understanding; the contracted version or the version required by mandatory law shall prevail. Regulation (EU) 2016/679, Organic Law 3/2018 and the applicable consumer and product rules apply. Law 41/2002 applies only where a specific service has a healthcare nature. Consumers retain the mandatory protections and courts of their habitual residence.

29. Electronic record of consent

For each participant we record: identity; version, hash and copy of the text; date and time; language and country; product; pre-contractual information presented; and the status of each voluntary option, including grant, modification and withdrawal. The record is retained as evidence for the applicable legal periods and can be downloaded.

Checkboxes will not be pre-ticked. A single action will not be interpreted as consent for multiple purposes. Consent on behalf of another adult cannot be given from the purchaser’s account.

Consents

The checkboxes are presented independently and none is pre-ticked. Only the main consent is essential to provide the service; the others are voluntary, may be withdrawn at any time and do not affect the service purchased or its price.

☐  Mandatory. I have read and accept the Informed Consent and the Terms and Conditions, and I give my explicit consent for Vivabioma to analyse my sample and process the data resulting from the analysis of my microbiome in order to provide the service. I declare that I am over 18 years of age or that I act as a duly documented legal representative. I have been offered the option to purchase a consultation with qualified professionals, before and after receiving the results and at an additional cost indicated on the platform, and I choose to continue without it for the time being, knowing that I may request it whenever I wish.

☐  Voluntary. I want to support science and the development of new treatments: I authorise the use of my data, in pseudonymised or aggregated form, in research projects. I understand that this includes collaborations and commercial agreements with universities and companies, and the development and training of artificial intelligence models. Information that directly identifies me will not be shared, I may withdraw this authorisation at any time, and my decision will not affect the service purchased.

☐  Voluntary. I want to receive updates, news and special offers from Vivabioma. I can unsubscribe at any time.

Professional Access is not authorised here: your consent is requested when you activate it, when the recipient, the information shared and its duration can be identified. Combining your data with data from another GENELINK service and research using the physical sample each require separate, specific consent.

Annex I. Country-specific particulars

Transport of human samples, module availability, professional involvement and regulatory classification vary by territory. The platform applies the declared country and may request documentation, limit results or prevent contracting. This annex is not an exhaustive inventory and is supplemented by the territory-specific information shown before payment.

Where an authority or law requires a prescription, professional advice, a specific laboratory, clinical confirmation, product registration or additional information, Vivabioma will adapt the pathway and will not enable the module until the requirement has been met.

Annex II. Glossary

Gut microbiome. Microorganisms in the intestine and their genetic material; the term is used here to describe the subject of the analysis, not the human genome.

Shotgun metagenomics. High-throughput sequencing of the genetic material in a sample without first selecting a single gene, followed by computational filtering and classification.

Relative abundance. Estimated proportion of the classified total; it is not an absolute quantity and does not demonstrate viability.

Potential function. Capacity inferred from genes or profiles; it is not equivalent to activity, a measured metabolite or an effect in the person.

Resistome. Genes associated with antimicrobial resistance in a community; it is not equivalent to clinical resistance or antimicrobial susceptibility testing.

Opportunistic pathogen. A microorganism that may be present without disease and be associated with infection only in certain contexts.

Pseudonymisation. Replacement of identifiers with a code; the data remain personal data if they can be linked using separate information.

Anonymisation. An irreversible process after which it is not reasonably possible to link data to a person; it must not be confused with pseudonymisation.